AbbVie (NY:ABBV)Price and VolumeDetailed Quote
Top NewsMore News
Via MarketBeat
Topics
Intellectual Property
Performance
52-Week Range
3.3% below 52-week high
288.84
190.7552W Low
298.7452W High
1 Week
3.3% below 1-week high
281.231W Low
298.741W High
AbbVie (ABBV) traded between $190.75 and $298.74 over the past 52 weeks and last traded at $288.84, 3.3% below its 52-week high. Over the past week it ranged between $281.23 and $298.74.
Past 12 Months
+0.9%
+8.7%
+17.8%
+38.8%
+26.0%
+36.3%
1W
+$2.45
1M
+$23.08
3M
+$43.74
6M
+$80.68
YTD
+$59.53
1Y
+$76.88
ABBV was +36.3% over the past year, +38.8% over six months, +26.0% year to date, +0.9% in the last week.
12 Months vs Market
ABBV
DIA
SPY
QQQ
IWM
Over the past 12 months ABBV returned +36.3% versus DIA (Dow) +9.7%, SPY (S&P 500) +10.1%, QQQ (Nasdaq 100) +7.8% and IWM (Russell 2000) +13.7%.
Volume & Liquidity
1.85× 3-mo avg
Today 8,850,115
3-mo avg 4.8M
1W
1M
3M
6M
YTD
1Y
ABBV most recently traded 8,850,115 shares against a 3-month average daily volume of 4.8M. More NewsRead More
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027? ↗
November 02, 2026
Via The Motley Fool
Topics
Intellectual Property
Via The Motley Fool
Topics
Intellectual Property
The top 5 analyst questions from AbbVie’s Q3 earnings call
November 01, 2026
Via StockStory
Topics
Earnings
AbbVie: 3 Key Takeaways for Long-Term Investors ↗
October 31, 2026
Via The Motley Fool
Is AbbVie a Buy After Its Latest Earnings Report? ↗
October 31, 2026
Via The Motley Fool
Topics
Intellectual Property
AbbVie (ABBV) Q3 2026 Earnings Call Transcript ↗
October 30, 2026
Via The Motley Fool
Topics
Earnings
What AbbVie (ABBV) Said on Its Q3 Earnings Call ↗
October 30, 2026
Via MarketBeat
Topics
Earnings
AbbVie (NYSE:ABBV) posts Q3 2026 sales in line with estimates
October 30, 2026
Via StockStory
AbbVie (ABBV) reports earnings tomorrow: what to expect
October 29, 2026
Via StockStory
Topics
Artificial Intelligence
Via The Motley Fool
Great News for AbbVie Stock Investors ↗
October 22, 2026
Via The Motley Fool
Topics
Intellectual Property
AbbVie vs. Bristol Myers Squibb: Faster Growth or Steady Revenue? ↗
October 21, 2026
Via The Motley Fool
Topics
Intellectual Property
AbbVie vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ↗
October 20, 2026
Via The Motley Fool
Topics
Intellectual Property
2 High-Flying Dividend Stocks to Buy and Hold for a Decade ↗
October 19, 2026
Via The Motley Fool
Topics
Intellectual Property
Via The Motley Fool
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle ↗
October 17, 2026
Via The Motley Fool
Topics
Credit Cards
Frequently Asked QuestionsIs AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 288.84
When was AbbVie last traded?
The last trade of AbbVie was at 11/02/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>